• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Xenon Pharmaceuticals Inc. - Common Shares (NQ:XENE)

36.50 UNCHANGED
Delayed Quote Updated: 4:00 PM EDT, Oct 22, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,643
Open 36.50
Bid (Size) 36.00 (1,000)
Ask (Size) 37.93 (100)
Prev. Close 36.50
Today's Range 36.50 - 36.50
52wk Range 33.38 - 72.66
Shares Outstanding 63,562,303
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 02, 2026
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
Xenon Files Azetukalner NDA as It Pauses Psychiatry Trials for Tolerability Review ↗
September 27, 2026
Xenon Pharmaceuticals (NASDAQ:XENE) said it has filed its first new drug application for azetukalner as a treatment for focal-onset seizures, while pausing portions of its late-stage psychiatry program... 
Via MarketBeat

Performance

52-Week Range 49.8% below 52-week high
36.50
33.3852W Low 72.6652W High
1 Week 1.4% below 1-week high
33.381W Low 37.001W High

Xenon Pharmaceuticals Inc. - Common Shares (XENE) traded between $33.38 and $72.66 over the past 52 weeks and last traded at $36.50, 49.8% below its 52-week high. Over the past week it ranged between $33.38 and $37.00.

Past 12 Months
+9.0%
-6.6%
-44.2%
-34.1%
-18.0%
-13.5%
1W +$3.01
1M -$2.59
3M -$28.92
6M -$18.91
YTD -$7.99
1Y -$5.68

XENE was -13.5% over the past year, -34.1% over six months, -18.0% year to date, +9.0% in the last week.

12 Months vs Market
XENE
-13.5%
DIA
+13.3%
SPY
+14.4%
QQQ
+16.3%
IWM
+13.7%

Over the past 12 months XENE returned -13.5% versus DIA (Dow) +13.3%, SPY (S&P 500) +14.4%, QQQ (Nasdaq 100) +16.3% and IWM (Russell 2000) +13.7%.

Volume & Liquidity 0.00× 3-mo avg
Today 3,643 3-mo avg 1.4M
1W
1.1M
1M
2.0M
3M
1.4M
6M
1.4M
YTD
1.4M
1Y
1.3M

XENE most recently traded 3,643 shares against a 3-month average daily volume of 1.4M.

More News

Read More
News headline image
XENE Investors Have Opportunity to Join Xenon Pharmaceuticals Inc. Fraud Investigation with SBS Law
September 23, 2026
From Schall, Brown & Schwartz LLP
Via Business Wire
Xenon Pharmaceuticals (NASDAQ:XENE) Presents High-Quality Technical Breakout Setup ↗
August 13, 2026
Via Chartmill
News headline image
Xenon to Present at TD Cowen Novel Mechanisms in Neuropsychiatry & Epilepsy Summit
September 21, 2026
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Triple Witching Whipsaws Wall Street While Crypto Stocks Steal the Show ↗
September 21, 2026
Via Chartmill
Top stock movements in today's session. ↗
September 18, 2026
Via Chartmill
Let's take a look at the stocks that are in motion in today's session. ↗
September 18, 2026
Via Chartmill
Friday's session: gap up and gap down stocks ↗
September 18, 2026
Via Chartmill
Stay updated with the stocks that are on the move in today's pre-market session. ↗
September 18, 2026
Via Chartmill
These stocks are moving in today's after hours session ↗
September 17, 2026
Via Chartmill
News headline image
Xenon Announces Azetukalner NDA Submission to FDA for Focal Seizures and Provides Update on Psychiatry Clinical Program
September 17, 2026
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
Xenon to Present at Wells Fargo Healthcare Conference
September 03, 2026
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 28, 2026
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
Xenon to Highlight Phase 3 X-TOLE2 Clinical Data and Rational Polytherapy Potential for Azetukalner at EEC 2026
August 26, 2026
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
Xenon Pharmaceuticals (XENE) Q2 2026 Earnings Call Transcript ↗
August 13, 2026
Via The Motley Fool
Topics Earnings
News headline image
Xenon Pharmaceuticals Q2 Earnings Call Highlights ↗
August 07, 2026
Via MarketBeat
Topics Earnings
News headline image
Xenon Reports Q2 2026 Financial Results and Provides Business Update
August 06, 2026
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 31, 2026
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
Xenon to Report Q2 2026 Financial Results on August 6, 2026
July 30, 2026
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 02, 2026
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 29, 2026
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
What to Know About This Fund’s New $22 Million Xenon Pharmaceuticals Buy Ahead of an FDA Filing ↗
May 18, 2026
Via The Motley Fool
News headline image
Xenon Pharmaceuticals Q1 Earnings Call Highlights ↗
May 09, 2026
Via MarketBeat
Topics Earnings
News headline image
Xenon (XENE) Q1 2026 Earnings Transcript ↗
May 07, 2026
Via The Motley Fool

Frequently Asked Questions

Is Xenon Pharmaceuticals Inc. - Common Shares publicly traded?
Yes, Xenon Pharmaceuticals Inc. - Common Shares is publicly traded.
What exchange does Xenon Pharmaceuticals Inc. - Common Shares trade on?
Xenon Pharmaceuticals Inc. - Common Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Xenon Pharmaceuticals Inc. - Common Shares?
The ticker symbol for Xenon Pharmaceuticals Inc. - Common Shares is XENE on the Nasdaq Stock Market
What is the current price of Xenon Pharmaceuticals Inc. - Common Shares?
The current price of Xenon Pharmaceuticals Inc. - Common Shares is 36.50
When was Xenon Pharmaceuticals Inc. - Common Shares last traded?
The last trade of Xenon Pharmaceuticals Inc. - Common Shares was at 10/22/26 04:00 PM ET
What is the market capitalization of Xenon Pharmaceuticals Inc. - Common Shares?
The market capitalization of Xenon Pharmaceuticals Inc. - Common Shares is 2.32B
How many shares of Xenon Pharmaceuticals Inc. - Common Shares are outstanding?
Xenon Pharmaceuticals Inc. - Common Shares has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap